Update README.md
Browse files
README.md
CHANGED
|
@@ -9,9 +9,9 @@ thumbnail: >-
|
|
| 9 |
https://cdn-uploads.huggingface.co/production/uploads/63c6c1f150cc81901da5d67f/VKPss0ChcvisJiBWBwW6x.png
|
| 10 |
---
|
| 11 |
|
| 12 |
-
<div style="border:1px solid #e1e4e8; border-radius:8px; padding:20px; max-width:
|
| 13 |
<h1 align="middle" style="margin-top:0; font-size:1.5em;">Silico Biosciences</h1>
|
| 14 |
-
<p style="margin:8px 0;">Where AI meets scalable, reliable drug development.</p>
|
| 15 |
<p style="font-size:0.9em;">
|
| 16 |
Silico Biosciences is an AI-driven biotech organization focused on accelerating drug discovery using advanced computational models. We develop protein language models that generate and optimize antibody sequences, aiming to turn <i>in silico</i> approaches into life-saving therapeutic molecules. Our flagship project, <a href="https://huggingface.co/collections/silicobio/peleke-1" target="_blank"><strong>🦋 peleke-1</strong></a>, is a suite of targeted antibody sequence generation models.
|
| 17 |
</p>
|
|
|
|
| 9 |
https://cdn-uploads.huggingface.co/production/uploads/63c6c1f150cc81901da5d67f/VKPss0ChcvisJiBWBwW6x.png
|
| 10 |
---
|
| 11 |
|
| 12 |
+
<div style="border:1px solid #e1e4e8; border-radius:8px; padding:20px; max-width:800px; font-family:Poppins, sans-serif; margin-left: auto; margin-right: auto;">
|
| 13 |
<h1 align="middle" style="margin-top:0; font-size:1.5em;">Silico Biosciences</h1>
|
| 14 |
+
<p align="middle" style="margin:8px 0;">Where AI meets scalable, reliable drug development.</p>
|
| 15 |
<p style="font-size:0.9em;">
|
| 16 |
Silico Biosciences is an AI-driven biotech organization focused on accelerating drug discovery using advanced computational models. We develop protein language models that generate and optimize antibody sequences, aiming to turn <i>in silico</i> approaches into life-saving therapeutic molecules. Our flagship project, <a href="https://huggingface.co/collections/silicobio/peleke-1" target="_blank"><strong>🦋 peleke-1</strong></a>, is a suite of targeted antibody sequence generation models.
|
| 17 |
</p>
|